Qipeng Shu

4PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
The Use of Curcumin to Target Oxidative Stress and Inflammation in Type 2 Diabetes Mellitus and Its Complications: Molecular Mechanisms and Therapeutic Perspectives.

|Aug 13, 2026
Regulation of VISA/MAVS Signalosome Dynamics and Immune Homeostasis.

|Aug 29, 2025
CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer.

Hai-Meng Zhou, Yi Liu, Feng Shi

|May 09, 2024
CLK2 mediates IκBα-independent early termination of NF-κB activation by inducing cytoplasmic redistribution and degradation.

Shang-Ze Li, Qi-Peng Shu, Hai-Meng Zhou

Pageof 1

Frequent Collaborators

3 joint publications

Shangze Li

2 joint publications

Yu-Ying Liu

2 joint publications

Xiao-Dong Zhang

2 joint publications

Run-Lei Du